Cargando…
HER2–CDH1 Interaction via Wnt/B-Catenin Is Associated with Patients’ Survival in HER2-Positive Metastatic Gastric Adenocarcinoma
SIMPLE SUMMARY: A deeper understanding of the molecular mechanisms involved in gastric cacner (GC) pathologenesis would help the identification of prognostic biomarkers and the development of new treatments. Human epidermal growth factor receptor 2 (HER2/ErbB2), a membrane-bound receptor of the EGFR...
Autores principales: | De Re, Valli, Alessandrini, Lara, Brisotto, Giulia, Caggiari, Laura, De Zorzi, Mariangela, Casarotto, Mariateresa, Miolo, Gianmaria, Puglisi, Fabio, Garattini, Silvio Ken, Lonardi, Sara, Cannizzaro, Renato, Canzonieri, Vincenzo, Fassan, Matteo, Steffan, Agostino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909509/ https://www.ncbi.nlm.nih.gov/pubmed/35267574 http://dx.doi.org/10.3390/cancers14051266 |
Ejemplares similares
-
Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype
por: Caggiari, Laura, et al.
Publicado: (2017) -
Overview of Epstein–Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options
por: Re, Valli De, et al.
Publicado: (2020) -
A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach
por: Caggiari, Laura, et al.
Publicado: (2017) -
Family’s History Based on the CDH1 Germline Variant (c.360delG) and a Suspected Hereditary Gastric Cancer Form
por: Caggiari, Laura, et al.
Publicado: (2020) -
Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients
por: Corona, Giuseppe, et al.
Publicado: (2018)